NDC11 45963055611
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 45963-0556-11 | 45963-0556 |
| 45963-556-11 | 45963-556 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Actavis Pharma, Inc. | 5969871e-6c71-4c37-9d63-370718ccc80c | 2025-05-01 | Warnings, Adverse reactions | 45963-556-11 45963-556 45963055611 |
| Gaba 300-EZS | GABAPENTIN | PureTek Corporation | bb29692e-1546-4d05-a46a-93baf4172c7d | 2020-11-16 | Warnings, Adverse reactions | 45963-556-11 45963055611 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.